胃癌与肿瘤相关蛋白的研究进展
The Progress Study of Gastric Cancer and Tumor Associated Protein

作者: 高希春 :河西学院附属张掖人民医院放射科,甘肃 张掖;

关键词: 胃癌肿瘤相关蛋白癌基因Gastric Cancer Tumor Associated Protein Cancer Gene

摘要:
胃癌在全球范围内发病率和死亡率均较高,严重地影响人类健康,其治疗效果和预后是临床普遍关注的问题。而且术后的辅助化疗已经成为进展期胃癌综合治疗的重要组成部分。随着对肿瘤分子生物学和化疗分子机制的了解,发现胃癌的发生与发展是多种基因表达紊乱积累的结果。结果表明:通过分子生物学方法对患者的基因进行检测,研究影响胃癌预后的相关因素,对改善胃癌患者的预后,提高生存率具有重要的意义。

Abstract: Morbidity and mortality of gastric cancer worldwide are high, seriously affecting human health. The treatment effect and prognosis are the clinical common concern. And postoperative adjuvant chemotherapy has become an important part of combination therapy for advanced gastric cancer. With the understanding of tumor molecular biology and molecular mechanism of chemotherapy, it is found that the occurrence and development of gastric cancer are the results of a variety of gene expression disorder accumulation. Results show that by means of molecular biology in patients with genetic testing, studying the related factors influencing the prognosis of gastric cancer has important significance to improve the prognosis of patients with gastric cancer and improve the survival rate.

文章引用: 高希春 (2016) 胃癌与肿瘤相关蛋白的研究进展。 亚洲肿瘤科病例研究, 5, 61-71. doi: 10.12677/ACRPO.2016.54007

参考文献

[1] 徐鹰, 王建明. 胃癌流行病学研究[J]. 中华肿瘤防治杂志, 2006, 13(1): 127-134.

[2] Richard, P., Lawrence, R.C., William, J.H., et al. (2004) Wagman Gastric Cancer. Cancer Management. 5th Edition, CMP Media LLC, New York, 259-272.

[3] 周鑫, 揭志刚. 胃癌个体化治疗[J]. 江西医学院学报, 2009, 49(4): 132-134.

[4] Smolka, M.B., Zhou, H., Purkayastha, S., et al. (2001) Optimization of the Iso-Tope-Coded Affinity Tag-Labeling Procedure for Quantitative Proteome Analysis. Analytical Biochemistry, 297, 25-31.
http://dx.doi.org/10.1006/abio.2001.5318

[5] Pierce, A., Unwin, R.D., Evans, C.A., et al. (2008) Eight-Channel iTRAQ Enables Comparison of the Activity of Six Leukemogenic Tyrosine Kinases. Molecular & Cellular Proteomics, 7, 853-863.
http://dx.doi.org/10.1074/mcp.M700251-MCP200

[6] Paul, D., Kumar, A., Gajbhiye, A., Santra, M.K., et al. (2013) Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture. BioMed Research International, .2013, Article ID: 783131.
http://dx.doi.org/10.1155/2013/783131

[7] Wang, J.X., Zhou, Y.N., Zou, S.J., et al. (2010) Correlations of p21-Activated Kinase 1 Expression to Clinic Pathological Features of Gastric Carcinoma and Patients’ Prognosis. Chinese Journal of Cancer, 29, 649-654.
http://dx.doi.org/10.5732/cjc.009.10709

[8] Halevy, O., Novitch, B.G., Spicer, D.B., et al. (1995) Correlation of Terminal Cell Cycle Arrest of Skeletal Muscle with Induction of p21 by My OD. Science, 267, 1018-1021.
http://dx.doi.org/10.1126/science.7863327

[9] Slingerdand, J. and Pagano, M. (2000) Regulation of the CDK Inhibitor P27 and Its Deregulation in Cancer. Journal of Cellular Physiology, 183, 10-17.
http://dx.doi.org/10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I

[10] Koh, T.Y. and Park, K.H. (2003) Inhibitory Effect of P27 Gene Transfer on Head Neck Squamous Cell Carcinoma Cell Lines. Heed Neck, 25, 44.
http://dx.doi.org/10.1002/hed.10166

[11] Park, K.H., Seol, J.Y., Yon, C.G., et al. (2001) Adenovirus Expressing p27(Kipl) Induces Growth Arrest of Long Cancer Cell Lines and Suppresses the Growth of Established Lung Cancer Xenografts. Lung Cancer, 31, 149-155.
http://dx.doi.org/10.1016/S0169-5002(00)00195-1

[12] Li, H.X., Chang, X.M., Song, Z.J., et al. (2003) Correlation between Expression of Cyciooxygenase-2 and Angiogenesis in Human Gastric Adenocarcinoma. World Journal of Gastroenterology, 9, 674-677.
http://dx.doi.org/10.3748/wjg.v9.i4.674

[13] Lenz, H.J. (2003) Clinical Update: Proteasome Inhibitors in Solid Tumors. Cancer Treatment Reviews, 29, 41-48.
http://dx.doi.org/10.1016/S0305-7372(03)00082-3

[14] Sirak, I., Petera, J., Hatlova, J., et al. (2009) Expression of p53, p21 and p16 Does Not Correlate with Response to Preoperative Chemoradiation in Gastric Carcinoma. Hepato-Gastroenterology, 56, 1213-1218.

[15] Gamboa-Dominguez, A., Seidl, S., Reyes-Gutierrez, E., et al. (2007) Prognostic Significance of p21WAF1/CIP1, p27Kip1, p53 and E-Cadherin Expression in Gastric Cancer. Journal of Clinical Pathology, 60, 756-761.
http://dx.doi.org/10.1136/jcp.2006.038976

[16] Shariat, S.F., Zlotta, A.R., Ashfaq, R., et al. (2007) Cooperative Effect of Cell-Cycle Regulators Expression on Bladder Cancer Development and Biologic Aggressiveness. Modern Pathology, 20, 445-459.
http://dx.doi.org/10.1038/modpathol.3800757

[17] Steeg, P., Bevilacqua, G., Kopper, L., et al. (1998) Evidence for a Gene Associated with Low Metastatic Potential. Journal of the National Cancer Institute, 80, 200-204.
http://dx.doi.org/10.1093/jnci/80.3.200

[18] Steeg, P. (2004) Perspectives on Classic Article: Metastasis Suppressor Genes. Journal of the National Cancer Institute, 17, E4.
http://dx.doi.org/10.1093/jnci/djh107

[19] Pennisi, E. (1997) New Tumor Suppressor Found Twice. Science, 275, 1876-1878.
http://dx.doi.org/10.1126/science.275.5308.1876

[20] Uegaki, K., et al. (2005) PTEN-Positive and Phosphorylated AKT-Negative Expression Is a Predictior of Survival for Patients with Advanced Endometrial Carcinoma. Oncology Reports, 14, 389-392.

[21] 朱宝和, 刘弋. PTEN基因与肿瘤浸润转移[J]. 国外医学肿瘤学分册, 2004, 31(3): 739-741.

[22] Reed, E., Dabholkar, M., Thornton, K., et al. (2000) Evidence for Order in the Appearance of mRNAs of Nucleotide Excision Repair Genes, in Humam Ovarian Cancer Tissues. Oncology Reports, 7, 1123-1128.

[23] Bernstein, C., Bernstein, H., Payne, C.M., et al. (2002) DNA Repair/Pro-Apoptotic Dual-Role Proteins in Five Major DNA Repair Pathways: Fail-Safe Protection against Carcinogenesis. Mutation Research, 511, 145-178.
http://dx.doi.org/10.1016/S1383-5742(02)00009-1

[24] 周彩存, 徐妍, 苏春霞, 等. 在非小细胞肺癌中表达及其临床意义[J]. 中国癌症志, 2006, 16(8): 622-625.

[25] 张萌, 刘巍, 等. 基因在食管癌中的研究进展[J]. 中国肿瘤杂志, 2009, 18(3): 218-221.

[26] Tripsianes, K., Folkers, G.E., et al. (2007) Analysis of the XPA and ssDNA-Binding Surfaces on the Central Domain of Human ERCC1 Reveals Evidence for Sub Functionalization. Nucleic Acids Research, 35, 5789-5798.
http://dx.doi.org/10.1093/nar/gkm503

[27] Zhou, W., Liu, G., Park, S., et al. (2005) Gene-Smoking Interaction Associations for the ERCC1 Polymorphisms in the Risk of Lung Cancer. Cancer Epidemiology Biomarkers & Prevention, 14, 491-496.
http://dx.doi.org/10.1158/1055-9965.EPI-04-0612

[28] 邵取非, 王佩飞, 郑聪, 等. 胃癌中PTEN, cyclinE蛋白表达及临床意义[J]. 全科医学临床与教育, 2008, 6(6): 478-483.

[29] 李志琴, 章静波. 细胞周期调控与肿瘤[J]. 癌症进展杂志, 2004, 2(1): 70-75.

[30] Murray, A.W. and Mark, D. (2001) Can Sequencing Shed Light on Cell Cycling. Nature, 294, 173-177.
http://dx.doi.org/10.1038/35057033

[31] 石玉宝, 李勇, 范立侨, 等. CyclinE和P27kip1蛋白表达与胃癌临床生物学行为关系的研究[J]. 中国现代医学杂志, 2009, 19(20): 3087-3090.

[32] Musman, J.G., Horn, H.F., Carroll, D.E., et al. (2000) Synergistic Induction of Centrosome Hyperamplification by Loss of p53 and Cycline Overexpression. Oncogene, 19, 1635-1646.
http://dx.doi.org/10.1038/sj.onc.1203460

[33] Hatakeyama, S., Watanabe, M., Fujii, Y., et al. (2005) Targeted Destruction of c-Myc by Anengineered Ubiquitin Ligase Suppresses Cell Transformation and Tumor Formation. Cancer Research, 65, 7874-7879.

[34] Hemann, M.T., Brie, A., Teruya-Feldstein, J., et al. (2005) Evasion of the P53 Tumor Surveillance Network by Tumour-Derived MYC Mutants. Nature, 436, 787-789.
http://dx.doi.org/10.1038/nature03845

[35] Shachaf, C.M. and Felsher, D.W. (2005) Tumor Dormancy and MYC Inactivation: Pushing Cancer to the Brink of Normalcy. Cancer Research, 65, 4471-4474.
http://dx.doi.org/10.1158/0008-5472.CAN-05-1172

[36] 陈迪生. Galectin-3在胃癌及其转移淋巴结中表达与临床意义[J]. 广东医学, 2005, 26(1): 51-53.

[37] 任慧梅, 李梅. P27蛋白表达与胃癌发生及临床病理特征的关系[J]. 大连医科大学学报, 2006, 27(5): 25-26.

[38] 刘言厚, 宫月华. 1992-2005年辽宁庄河胃癌高发区1003例胃癌病理形态学特征年代变化趋势[J]. 中华肿瘤防治杂志, 2007, 14(2): 96-99.

[39] Cullen, B.R. (2004) Transcription and Processing of Human MicroRNA Precursors. Molecular Cell, 16, 861-865.
http://dx.doi.org/10.1016/j.molcel.2004.12.002

[40] Hammond, S.M. (2006) MicroRNAs as Oncogenes. Current Opinion in Genetics & Development, 16, 4-9.
http://dx.doi.org/10.1016/j.gde.2005.12.005

[41] Zhang, I., Huang, I., Yang, N., et al. (2006) MicroRNAs Exhibit High Frequency Genomic Alterations in Human Cancer. Proceedings of the National Academy of Sciences of the United States of America, 103, 9136-9141.
http://dx.doi.org/10.1073/pnas.0508889103

[42] Honeycutt, K.A., Chen, Z., Koster, M.I., et al. (2006) Deregulated Mini2 Chromosomal Maintenance Protein MCM7 Contributes to Oncogene Driven Tumorigenesis. Oncogene, 25, 4027-4032.
http://dx.doi.org/10.1038/sj.onc.1209435

[43] Ito, K., Liu, Q., Salto-Tellez, M., et al. (2006) RUNX3, a Novel Tumor Sup-pressor, Is Frequently Inactivated in Gastric Cancer by Protein Mislocalization. Cancer Research, 66, 3345.

[44] Fukamachi, H. (2006) Runx3 Controls Growth and Differentiation of Gastric Epithelial Cells in Mammals. Development Growth and Differentiation, 48, 1-13.
http://dx.doi.org/10.1111/j.1440-169X.2006.00832.x

[45] Gao, N., Chen, W.C. and Cen, J.N. (2008) Relationship between Runx3 Gene Expression and Its DNA Methylation in Gastric Cancer. Chinese Journal of Oncology, 30, 361-364.

[46] Ai, Z., Yin, L., Zhou, X., et al. (2006) Inhibition of Surviving Reduces Cess Proliferation and Induces Apoptosis in Human Endometrial Cancer. Cancer, 107, 746-756.
http://dx.doi.org/10.1002/cncr.22044

[47] Yonemnra, Y., Endo, Y., Tabata, K., et al. (2005) Role of VEGF-C and VEGF-D in Lymphangiogenesis in Gastric Cancer. International Journal of Clinical Oncology, 10, 318-327.
http://dx.doi.org/10.1007/s10147-005-0508-7

[48] Ishikawa, M., Kitayama, J., Kazama, S., et al. (2003) Expression of Vascular Endothelial Growth Factor C and D (VEGF-C and-D) Is an Important Risk Factor for Lymphatic Metastasis in Undifferentiated Early Gastric Carcinoma. Japanese Journal of Clinical Oncology, 33, 21-27.
http://dx.doi.org/10.1093/jjco/hyg008

[49] Deng, J., Liang, H., Sun, D., et al. (2009) Vascular Endothelial Growth Factor-D Is Correlated with Hepatic Metastasis from Gastric Cancer after Radical Gastrectomy. Surery, 146, 896-905.
http://dx.doi.org/10.1016/j.surg.2009.04.025

[50] Ezoe, S., Matsumura, I., Nakata, S., et al. (2002) GATA-2/Estrogen Receptor Chimera Regulates Cytokine-Dependent Growth of Hematopoietic Cells through Accumul-Ation of p21WAFl and p27kipl Proteins. Blood, 100, 3512-3513.
http://dx.doi.org/10.1182/blood-2002-04-1177

[51] Carrano, A.C. and Pangano, M. (2001) Role of the F-Box Protein Skp2 in Adhesion Dependent Cell Cycle Progression. Cell Biology, 153, 1351-1390.
http://dx.doi.org/10.1083/jcb.153.7.1381

[52] Kim, S.Y., Herbst, A., Tworkowski, K.A., et al. (2003) Skp2 Regulates Myc Protein Stability and Activity. Molecular Cell, 11, 1177-1188.
http://dx.doi.org/10.1016/S1097-2765(03)00173-4

[53] Gou, Y., Shi, Y., Zhang, Y., Nie, Y., Wang, J., Song, J., Jin, H., He, L., Gao, L., Qiao, L., Wu, K. and Fan, D. (2010) Ribosomal Protein L6 Promotes Growth and Cell Cycle Progression through Upregulating Cyclin E in Gastric Cancer Cells. Biochemical and Biophysical Research Communications, 393,788-793.
http://dx.doi.org/10.1016/j.bbrc.2010.02.083

分享
Top